ZYTCA is proud to be exhibiting at BVA Live 2026, showcasing how our real‑time qPCR diagnostic technology is reshaping companion‑animal testing with greater accuracy, insight, and flexibility. Unlike traditional PCR or rapid tests that provide only a simple positive or negative result, ZYTCA’s real‑time platform delivers full Ct values, giving a clear indication of pathogen load and the likely stage of infection. This deeper level of insight allows veterinary teams to make faster, more informed, and more data‑driven clinical decisions during the same appointment.

A defining feature of ZYTCA’s diagnostic panels is that they are developed and validated using real clinical samples; not just in‑silico predictions or synthetic controls. Each test kit has two levels of in-built QC; giving confidence in every result. Every panel is built on real‑world data from genuine patient cases, ensuring that the assays reflect the complexity, variability, and pathogen loads seen in everyday veterinary practice. This commitment to clinical‑sample validation means our panels perform reliably in the real world, not just in the lab, giving vets confidence that results truly represent what is happening in the patient.

All of ZYTCA’s R&D, scientific development, and customer support operations are based in the UK at the Begbroke Science Park, part of the University of Oxford. Being embedded within this world‑class research environment enables our team to innovate rapidly, publish peer‑reviewed studies, and collaborate with leading global universities on emerging infectious disease, zoonotic risk, and One Health research. Our Oxford base also ensures clinics receive responsive, UK‑specific support from a team that understands the realities of first‑opinion practice, referral workflows, and the pressures facing modern veterinary teams.

ZYTCA is founded and led by two women with doctorate degrees, making us a women‑led organisation built on scientific rigour, inclusivity, and practical innovation. Our team includes dedicated veterinary nurse customer‑care specialists who support clinics with onboarding, workflow optimisation, and day‑to‑day case queries. Alongside them are two practising veterinarians with doctorates: Dr Marvin Firth, Director of Pathology and Partnerships, a board‑certified pathologist who provides expert case interpretation and clinical guidance; and Dr Matias Perez, a parasitologist and practising vet whose field experience ensures our panels reflect real‑world clinical needs. Together, they all offer a depth of expertise rarely found in diagnostic companies - giving both existing and prospective customers direct access to genuine veterinary insight whenever they need it.

We specialise in developing custom diagnostic panels tailored to the needs of individual practices; including a reptile panel designed and delivered in just four weeks — and every bespoke panel undergoes the same rigorous process of real‑clinical‑sample validation. This ensures that whether a clinic is testing dogs, cats, exotics, or more unusual species, the results are grounded in real‑life patient data, not theoretical models.

Beyond the UK, ZYTCA collaborates with universities, research institutes, and health organisations worldwide, contributing to studies in animal–human health, zoonotic disease surveillance, and preventative diagnostics. These partnerships ensure our panels remain clinically relevant, globally informed, and aligned with emerging pathogen trends.

With built‑in quality control in every kit, transparent Ct‑value reporting, real‑clinical‑sample validation, and highly competitive pricing, ZYTCA offers both scientific confidence and exceptional value. Visit our stand at BVA Live to meet the team and discover how personalised, precise, real‑time diagnostics can transform companion‑animal care in your practice.